The primary objective of the proposed study is to evaluate the safety and efficacy of Epidiolex (cannabidiol) in adults with obsessive compulsive and related disorders (OCRDs). Subjects will be treated in an open-label fashion with Epidiolex for two weeks.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Yale Brown Obsessive Compulsive Scale (YBOCS)
Timeframe: Baseline to Week 2
NIMH Symptom Severity Scale (for TTM or Skin Picking)
Timeframe: Baseline to Week 2
The Hoarding Rating Scale (HRS)
Timeframe: Baseline to Week 2
Yale Global Tic Severity Scale (YGTSS)
Timeframe: Baseline to Week 2